[HTML][HTML] Selective serotonin reuptake inhibitor-treatment does not show beneficial effects on cognition or amyloid burden in cognitively impaired and cognitively …
Y Bouter, C Bouter - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
Selective serotonin reuptake inhibitor-treatment does not show beneficial effects on cognition or amyloid burden in cognitively impaired and cognitively normal …
Y Bouter, C Bouter - Frontiers in Aging Neuroscience, 2022 - psycnet.apa.org
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal …
Y Bouter, C Bouter - Frontiers in Aging Neuroscience, 2022 - europepmc.org
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal …
Y Bouter, C Bouter - Frontiers in Aging Neuroscience, 2022 - search.ebscohost.com
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal …
Y Bouter, C Bouter - Frontiers in Aging Neuroscience, 2022 - search.proquest.com
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal
K Endres, GS Kranz, A Fellgiebel - Women in aging …, 2023 - books.google.com
Alzheimer's disease (AD), the most common form of dementia, is a progressive
neurogenerative disease characterized by memory loss and decline of cognitive function …
neurogenerative disease characterized by memory loss and decline of cognitive function …
Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal …
Y Bouter, C Bouter - Frontiers in aging neuroscience, 2022 - pubmed.ncbi.nlm.nih.gov
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal …
Y Bouter, C Bouter - 2022 - publications.goettingen-research …
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
[HTML][HTML] Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively …
Y Bouter, C Bouter - Frontiers in Aging Neuroscience, 2022 - ncbi.nlm.nih.gov
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …
beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to …